Optimization of surgical treatment of advanced ovarian cancer: a Spanish expert perspective
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Minig, L
- de Santiago, J
- Gil-Moreno, A
- Martinez, S
- Rodriguez-Garzotto, A
- Chiva, L
Grupos
Abstract
BackgroundOptimal upfront treatment of patients with advanced ovarian cancer is complex and requires the adequate function of a multidisciplinary team. Specific standard of quality of care needs to be taken into consideration.MethodsA literature search in PubMed was performed using the following criteria: (ovarian neoplasms[MeSH Terms] OR (ovarian[All Fields] AND neoplasms[All Fields]) OR ovarian neoplasms[All Fields] OR (ovarian[All Fields] AND cancer[All Fields]) OR ovarian cancer[All Fields])[Date - Publication]: 2018/01/14[Date - Publication]).ResultsThis article describes how to optimize the surgical management of advanced ovarian cancer, to achieve the best results in terms of survival and quality of life. For this purpose, this document will cover aspects related to pre-, intra- and postoperative care of newly diagnosed advanced ovarian cancer patients.ConclusionOptimizing upfront treatment of patients with advanced ovarian cancer is complex and requires a structured quality management program including the wise judgment of a multidisciplinary team. Surgeries performed by gynecologic oncologists with formal training in cytoreductive techniques at referral centers are crucial factors to obtain better clinical and oncological outcomes. However, other factors such as the patient's clinical status, the hospital infrastructure and equipment, as well as the tumor biology of each individual patient should also be taken into account before deciding on an initial therapeutic strategy for advanced-stage ovarian cancer to offer patients the best quality of care.
Datos de la publicación
- ISSN/ISSNe:
- 1699-048X, 1699-3055
- Tipo:
- Article
- Páginas:
- 656-664
- PubMed:
- 30377941
- Factor de Impacto:
- 0,833 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico SPRINGER-VERLAG ITALIA SRL
Citas Recibidas en Web of Science: 2
Documentos
- No hay documentos
Filiaciones
Keywords
- Ovarian cancer; Peritoneal carcinomatosis; Quality of care; Advanced stage; Optimization of treatment
Proyectos y Estudios Clínicos
ESTUDIO DE LA ENFERMEDAD METASTASICA EN EL TEJIDO OVARICO CRIOPRESERVADO DE MUJERES CON CANCER DE MAMA
Investigador Principal: ANTONIO PELLICER MARTÍNEZ
PI08/90483 . INSTITUTO DE SALUD CARLOS III . 2009
SEGURIDAD Y RENDIMIENTO DEL DISPOSITIVO DE CAPTURA DE CÉLULAS TUMORALES METASTÁSICAS EN PACIENTES CON CÁNCER OVÁRICO AVANZADO.
Investigador Principal: SANTIAGO DOMINGO DEL POZO
MTRAP-2016-01 . 2017
SENTOV: GANGLIO CENTINELA EN CÁNCER DE OVARIO EN ESTADIO INICIAL.
Investigador Principal: VÍCTOR LAGO LEAL
SENTOV . 2017
TAC TRAS CIRUGÍA DE CITORREDUCCIÓN EN CÁNCER DE OVARIO: NUEVO MARCADOR PRONÓSTICO.
Investigador Principal: VÍCTOR LAGO LEAL
SDP-BEV-2018-01
Cita
Minig L,de Santiago J,DOMINGO S,Gil A,Martinez S,Rodriguez A,Chiva L. Optimization of surgical treatment of advanced ovarian cancer: a Spanish expert perspective. Clin Transl Oncol. 2019. 21. (5):p. 656-664. IF:2,737. (3).